January 28, 2025

New Member: Welcome in our cluster to Menarini Biotech

New Member: Welcome in our cluster to Menarini Biotech
Go back

Menarini Biotech (MBH) is a leading CDMO specializing in Process Development and GMP manufacturing across various therapeutic areas. With a mission to be a reliable, agile, and innovative partner, MBH empowers its customers to bring life-saving biotherapeutics to patients through expertise in drug development.

From lab to production, cutting-edge technology accelerates processes, optimizes yields, and ensures precision at every stage. Guided by a vision of pioneering scientific breakthroughs, MBH applies innovative technologies to help find cures for difficult-to-treat diseases—transforming research insights into seamless clinical development.

If you would like to learn more, please visit their Website.
Looking forward to your active participation!

Our latest News

discover more
SPT Labtech to collaborate with Illumina to develop automated platform supporting genomics in decentralized healthcare settings

SPT Labtech to collaborate with Illumina to develop automated platform supporting genomics in decentralized healthcare settings

Cambridge, UK, 25 February 2026: SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, today announced a strategic collaboration with Illumina to develop a novel automated sample preparation platform designed to streamline and standardize genomics workflows across decentralized healthcare environments. The collaboration will focus on helping labs […]

read more
€1.48 Million in Federal Funding Secured for SAM3 Research Project at Mannheim University of Applied Sciences

€1.48 Million in Federal Funding Secured for SAM3 Research Project at Mannheim University of Applied Sciences

Mannheim University of Applied Sciences has been awarded approximately €1.48 million in federal funding for the research project SAM3 – Smart Applications for Multimodal Molecular Pattern Recognition (2026–2028). The funding is provided through the “HAW-ForschungsPraxis 2024” program of the German Federal Ministry for Research, Technology and Space. The project focuses on advancing biochemical analytics used […]

read more
Seeing cells in a new light

Seeing cells in a new light

Illuminating the tiniest details of living cells just got a major boost: Scientists at the Max Planck Institute for Medical Research have developed new markers that glow in the far-red range and are activated by light. They are stable, easy to control, and compatible with several super-resolution microscopy techniques, as outlined in a paper published […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp